Common Equity: The sum of all common equity items.
Pliant Therapeutics, Inc. (PLRX) had Common Equity of $146.93M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-22.37M |
|
-- |
|
-- |
|
$23.86M |
|
$-23.86M |
|
$1.49M |
|
$-22.37M |
|
$-22.37M |
|
$-22.37M |
|
$-22.37M |
|
$-22.37M |
|
$-22.37M |
|
$-23.86M |
|
$-23.73M |
|
61.92M |
|
61.92M |
|
$-0.36 |
|
$-0.36 |
|
| Balance Sheet Financials | |
$163.14M |
|
$2.41M |
|
$26.74M |
|
$189.88M |
|
$16.48M |
|
-- |
|
$26.47M |
|
$42.95M |
|
|
Common Equity |
$146.93M |
$146.93M |
|
$146.93M |
|
61.92M |
|
| Cash Flow Statement Financials | |
$-32.03M |
|
$11.39M |
|
$0.07M |
|
$46.93M |
|
$26.36M |
|
$-20.56M |
|
$8.44M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.90 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-31.91M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-15.23% |
|
-15.23% |
|
-11.78% |
|
-15.23% |
|
$2.37 |
|
$-0.52 |
|
$-0.52 |
|